In Stock, Ready to Ship!
$60.00
Semax Amidate is a stabilized heptapeptide analog of the endogenous ACTH fragment, designed for preclinical studies of cognitive function, neuroprotection, and stress resilience. In rodent learning-and-memory tasks and neuronal-culture models, Semax modulates BDNF expression, supports antioxidant defenses, and regulates stress-axis markers. Each 10 mg vial is USA-manufactured, HPLC-verified to ≥ 99% purity, endotoxin-screened (< 0.1 EU/mg), and tailored for laboratory research.
Peptides are not ready to use. Must purchase BAC water for reconstitution.
In controlled laboratory studies, models administered retatrutide exhibited an average reduction equivalent to approximately 24% of baseline mass over a 48-week evaluation period. These findings are based on Phase-2 data and should be interpreted within the scope of scientific research only.
For research use only. Not for human or veterinary use.
Retatrutide is a tri-agonist peptide shown in laboratory studies to simultaneously activate GLP-1, GIP, and glucagon receptors. This unique combination has been observed to influence appetite signaling pathways and support energy regulation in research models.
For laboratory research use only. Not for human or animal use.
In controlled laboratory studies, Retatrutide has been observed to influence biomarkers such as HbA1c, fasting glucose levels, and insulin sensitivity in experimental models. These findings suggest potential metabolic modulation for further investigation.
For research use only. Not for human consumption or therapeutic application.
Research trials often employ a once-weekly subcutaneous micro-dosing approach, typically around 0.1 mL, to maintain consistent exposure levels in peptide models. This allows for sustained analysis without requiring daily administration.
For research use only. Not approved for human consumption or clinical use.
Research models receiving GLP-1 class peptides such as Retatrutide have shown mild and temporary gastrointestinal reactions, generally decreasing as dosage protocols are stabilized. These observations are consistent with GLP-1-related pathways in research.
Retatrutide is not intended for human or diagnostic use. For qualified research personnel only.
Semax Amidate is a chemically modified version of the ACTH(4–10) fragment, engineered with C-terminal amidation for enhanced stability. As a nootropic and neuroprotective research peptide, it interacts with neurotrophic and stress-response pathways—making it ideal for exploring BDNF-mediated plasticity, oxidative-stress defenses, and behavioral-stress modulation in vitro and in vivo models.
Unlike unmodified peptides, Semax Amidate’s C-terminal amidation and sequence tweaks confer extended enzymatic resistance and improved blood-brain-barrier penetration in rodent models. It uniquely combines cognitive-boosting and neuroprotective effects without affecting systemic hormone levels. This makes Semax Amidate the go-to peptide for dissecting synaptic plasticity, stress resilience, and cell-survival mechanisms in high-resolution preclinical assays.
In vitro ranges span 100 nM–10 µM; in vivo rodent doses often use 0.1–1 mg/kg per protocol.
Store lyophilized at – 20 °C; keep reconstituted peptide at 2–8 °C and use within 7 days.
No—Semax Amidate is strictly for research use only and not approved for human or veterinary application.
Don't hestitate to contact us
End of Content.
